Novabay Pharmaceuticals Inc

ASE:NBY   3:56:38 PM EDT
0.73
+0.01 (+1.52%)
Earnings Announcements

NovaBay Pharmaceuticals Reports 2020 Fourth Quarter And Full Year Financial Results

Published: 03/25/2021 20:27 GMT
Novabay Pharmaceuticals Inc (NBY) - Novabay Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results.
Q4 Loss per Share $0.04.
Novabay Pharmaceuticals - Net Product Revenue for Q4 of 2020 Was $1.9 Million, a 10% Increase From $1.7 Million for Q4 of 2019.
Revenue is expected to be $2.55 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $2.86 Million
Next Quarter EPS Guidance is expected to be -$0.03

More details on our Analysts Page.